Back
Sarepta Therapeutics Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
36
SRPT
Sarepta Therapeutics
Last Price:
$118.99
Seasonality Move:
12.18%
7 Day Trial
ALL ACCESS PASS
$
7
Trump's Legacy-Defining Momentor Strike
But the Surprising Way Trump Solves it Could Cement His Legacy.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.
Sarepta Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 123.1 | Sell |
| 20-day SMA: | 125.31 | Sell |
| 50-day SMA: | 122.99 | Sell |
| 200-day SMA: | 129.64 | Sell |
| 8-day EMA: | 122.43 | Sell |
| 20-day EMA: | 123.17 | Sell |
| 50-day EMA: | 123.7 | Sell |
| 200-day EMA: | 126 | Sell |
Sarepta Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.02 | Sell |
| Relative Strength Index (14 RSI): | 43.28 | Sell |
| Chaikin Money Flow: | -1117882 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (112.92 - 130.54) | Sell |
| Bollinger Bands (100): | (118.37 - 135.77) | Sell |
Sarepta Therapeutics Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Sarepta Therapeutics Stock
Is Sarepta Therapeutics Stock a Buy?
-
Sarepta Therapeutics share price is 118.97 while SRPT 8-day simple moving average is 123.10, which is a Sell signal.
-
The stock price of SRPT is 118.97 while Sarepta Therapeutics 20-day SMA is 125.31, which makes it a Sell.
-
Sarepta Therapeutics 50-day simple moving average is 122.99 while SRPT share price is 118.97, making it a Sell technically.
-
SRPT stock price is 118.97 and Sarepta Therapeutics 200-day simple moving average is 129.64, creating a Sell signal.
SRPT Technical Analysis vs Fundamental Analysis
Sell
36
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy or a Sell?
-
Sarepta Therapeutics stock is rated a SellThe current Sarepta Therapeutics [SRPT] share price is $118.97. The Score for SRPT is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
Sarepta Therapeutics Stock Info
Market Cap:
11.4B
Price in USD:
118.97
Share Volume:
1.7M
Sarepta Therapeutics 52-Week Range
52-Week High:
173.25
52-Week Low:
91.34
Sell
36
Sarepta Therapeutics (SRPT)
is a Sell
Sarepta Therapeutics Share Price Forecast
-
What is the Sarepta Therapeutics stock price today?The Sarepta Therapeutics stock price is 118.97 USD today.
-
Will SRPT stock go up or go down?Sarepta Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Sarepta Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Sarepta Therapeutics is overvalued.
Is Sarepta Therapeutics Stock a Buy?
-
Sarepta Therapeutics share price is 118.97 while SRPT 8-day exponential moving average is 122.43, which is a Sell signal.
-
The stock price of SRPT is 118.97 while Sarepta Therapeutics 20-day EMA is 123.17, which makes it a Sell.
-
Sarepta Therapeutics 50-day exponential moving average is 123.70 while SRPT share price is 118.97, making it a Sell technically.
-
SRPT stock price is 118.97 and Sarepta Therapeutics 200-day simple moving average is 126.00, creating a Sell signal.
Fundamental Analysis of Sarepta Therapeutics
Is Sarepta Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $2.79 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.75 per share, and an increase next year of $7.84 per share.
Technical Analysis of Sarepta Therapeutics
Should I short Sarepta Therapeutics stock?
-
SRPT Moving Average Covergence Divergence (MACD) indicator is -0.02, suggesting Sarepta Therapeutics is a Sell
-
Sarepta Therapeutics Relative Strength Index (RSI) is 43.28, which suggest Sarepta Therapeutics is oversold
-
The Bollinger Bands (25) for Sarepta Therapeutics is (112.92 - 130.54), which suggest Sarepta Therapeutics is a Sell
-
The Bollinger Bands (100) for Sarepta Therapeutics is (118.37 - 135.77), which suggest Sarepta Therapeutics is a Sell
* Sarepta Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.